These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 16651433

  • 1. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.
    Nilsson UW, Dabrosin C.
    Cancer Res; 2006 May 01; 66(9):4789-94. PubMed ID: 16651433
    [Abstract] [Full Text] [Related]

  • 2. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Bendrik C, Robertson J, Gauldie J, Dabrosin C.
    Cancer Res; 2008 May 01; 68(9):3405-12. PubMed ID: 18451168
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
    Nilsson UW, Jönsson JA, Dabrosin C.
    Exp Cell Res; 2009 Jan 01; 315(1):1-9. PubMed ID: 18996114
    [Abstract] [Full Text] [Related]

  • 4. MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells.
    Nilsson UW, Garvin S, Dabrosin C.
    Breast Cancer Res Treat; 2007 May 01; 102(3):253-61. PubMed ID: 17031577
    [Abstract] [Full Text] [Related]

  • 5. Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer.
    Bendrik C, Karlsson L, Dabrosin C.
    Cancer Lett; 2010 Jun 01; 292(1):32-40. PubMed ID: 19944523
    [Abstract] [Full Text] [Related]

  • 6. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P, Yan L.
    Cancer Res; 2005 Apr 15; 65(8):3193-9. PubMed ID: 15833850
    [Abstract] [Full Text] [Related]

  • 7. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
    Garvin S, Dabrosin C.
    Cancer Res; 2003 Dec 15; 63(24):8742-8. PubMed ID: 14695189
    [Abstract] [Full Text] [Related]

  • 8. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
    Lindahl G, Saarinen N, Abrahamsson A, Dabrosin C.
    Cancer Res; 2011 Jan 01; 71(1):51-60. PubMed ID: 21097717
    [Abstract] [Full Text] [Related]

  • 9. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
    Du Z, Hou S.
    J Urol; 2003 Nov 01; 170(5):2000-3. PubMed ID: 14532841
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D, tamoxifen and beta-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium.
    Paduch R, Kandefer-Szerszeń M.
    Cell Biol Toxicol; 2005 Nov 01; 21(5-6):247-56. PubMed ID: 16323060
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
    Williams RN, Parsons SL, Morris TM, Rowlands BJ, Watson SA.
    Eur J Surg Oncol; 2005 Nov 01; 31(9):1042-50. PubMed ID: 15993560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparison of the effect of rh-endostatin on intratumoral and myocardial micrangium in mice].
    Zhang CC, Li K, Wei XY, Chen C, Yuan J, Wang J.
    Zhonghua Zhong Liu Za Zhi; 2011 Jun 01; 33(6):415-20. PubMed ID: 21875480
    [Abstract] [Full Text] [Related]

  • 16. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.
    Kim YM, Jang JW, Lee OH, Yeon J, Choi EY, Kim KW, Lee ST, Kwon YG.
    Cancer Res; 2000 Oct 01; 60(19):5410-3. PubMed ID: 11034081
    [Abstract] [Full Text] [Related]

  • 17. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer.
    Djonov V, Cresto N, Aebersold DM, Burri PH, Altermatt HJ, Hristic M, Berclaz G, Ziemiecki A, Andres AC.
    Int J Oncol; 2002 Jul 01; 21(1):25-30. PubMed ID: 12063545
    [Abstract] [Full Text] [Related]

  • 18. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
    Pozzi A, LeVine WF, Gardner HA.
    Oncogene; 2002 Jan 10; 21(2):272-81. PubMed ID: 11803470
    [Abstract] [Full Text] [Related]

  • 19. Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study.
    Abdallah MA, Abdullah HI, Kang S, Taylor DD, Nakajima ST, Gercel-Taylor C.
    Fertil Steril; 2007 Apr 10; 87(4):978-81. PubMed ID: 17207794
    [Abstract] [Full Text] [Related]

  • 20. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
    Lu M, Miller KD, Gokmen-Polar Y, Jeng MH, Kinch MS.
    Cancer Res; 2003 Jun 15; 63(12):3425-9. PubMed ID: 12810680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.